Sobi® has received approval from the European Commission for ALTUVOCT™, a replacement therapy designed for treating and preventing bleeds, as well as for perioperative prophylaxis in individuals with hemophilia

The CMT Research Foundation, committed to finding treatments for Charcot-Marie-Tooth disease (CMT), has teamed up with ReviR Therapeutics. Their collaboration aims to develop small molecule therapies

AbbVie has announced that the U.S. Food and Drug Administration has approved SKYRIZI® for adults suffering from moderately to severely active ulcerative colitis. This marks the first approval

Assembly Biosciences, Inc., a biotechnology company specializing in novel therapies for serious viral diseases, has announced the commencement of dosing for the Phase 1b trial of ABI-4334

Johnson & Johnson has filed a Biologics License Application with the U.S. Food and Drug Administration for a fixed combination of amivantamab and recombinant human hyaluronidase intended

SpineThera, Inc., a company specializing in long-acting injectable technologies, has announced a new partnership with Mayo Clinic to develop treatments aimed at improving outcomes for those with substance abuse disorders.

UMC Utrecht has started its initial enrollment for a study focused on discovering biomarkers for Amyotrophic Lateral Sclerosis. This research, led by Professor Dr. Leonard van den Berg

Enveda Biosciences, a biotechnology firm that uses artificial intelligence to develop new medicines from natural sources, has raised $55 million in its latest funding round, adding to the $119 million previously secured in Series B

CyanVac LLC, a biotechnology firm focused on clinical-stage development, has secured funding through Project NextGen to advance a Phase 2b clinical trial of its COVID-19 vaccine candidate, CVXGA.

Renova Therapeutics, a biotech company focused on creating gene therapy solutions for cardiovascular and metabolic conditions, has disclosed its strategic plans to expand the therapeutic use of its gene therapies